Oxford Biomedica plc (OXB.L)
GBp 425.5
(1.07%)
GBp 425.5
(1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 89.53 Million | 139.98 Million | 142.79 Million | 87.72 Million | 64.06 Million | 66.77 Million |
| Cost of Revenue | 49.81 Million | 70.8 Million | 60.15 Million | 41.65 Million | 35.72 Million | 22.76 Million |
| Gross Profit | 39.72 Million | 69.18 Million | 82.64 Million | 46.07 Million | 28.33 Million | 44.01 Million |
| Operating Expenses | 223.9 Million | 120.73 Million | 61.7 Million | 50.93 Million | 40.92 Million | 36.08 Million |
| Selling, General and Administrative Expenses | 25.41 Million | 28.22 Million | 15.15 Million | 11.26 Million | 11.88 Million | 7.43 Million |
| Research and Development Expenses | 59.35 Million | 60.93 Million | 40.18 Million | 29.74 Million | 22.54 Million | 29.71 Million |
| Other Expenses | 139.13 Million | 31.57 Million | 6.36 Million | 9.92 Million | 6.49 Million | -1.06 Million |
| Cost and Expenses | 273.71 Million | 191.54 Million | 121.86 Million | 92.59 Million | 76.64 Million | 58.84 Million |
| Operating Income | -184.17 Million | -51.55 Million | 20.76 Million | -4.82 Million | -12.58 Million | 8 Million |
| Interest Expense | 11.19 Million | 16.72 Million | 888 Thousand | 912 Thousand | 6.52 Million | 8.97 Million |
| Income Tax Expense | -4.36 Million | -817 Thousand | 869 Thousand | -327 Thousand | -4.82 Million | -2.52 Million |
| Earnings before Tax | -188.52 Million | -45.97 Million | 19.88 Million | -6.57 Million | -20.88 Million | 5.01 Million |
| Net Income | -157.49 Million | -45.15 Million | 19.01 Million | -6.24 Million | -16.06 Million | 7.54 Million |
| Earnings Per Share Basic | -1.63 | -0.48 | 0.23 | -0.08 | -0.22 | 0.11 |
| Earnings Per Share Diluted | -1.63 | -0.48 | 0.22 | -0.08 | -0.22 | 0.11 |
| Weighted Average Shares Outstanding | 96.55 Million | 94.82 Million | 83.48 Million | 79.94 Million | 72.7 Million | 69.24 Million |
| Weighted Average Shares Outstanding (Diluted) | 96.55 Million | 94.82 Million | 85.61 Million | 79.94 Million | 72.7 Million | 69.24 Million |
| Gross Margin | 0.44 | 0.49 | 0.58 | 0.53 | 0.44 | 0.66 |
| EBIT Margin | -1.66 | -0.17 | 0.23 | 0.06 | -0.10 | 0.19 |
| Profit Margin | -1.76 | -0.32 | 0.13 | -0.07 | -0.25 | 0.11 |
| EBITDA | -148.61 Million | -10.86 Million | 33.22 Million | 3.92 Million | -9.6 Million | 12.28 Million |
| Earnings Before Tax Margin | -2.06 | -0.37 | 0.15 | -0.06 | -0.20 | 0.12 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 50.8 Million | 89.53 Million | 46.47 Million | 43.06 Million | 139.98 Million | 75.96 Million |
| Cost of Revenue | 32.85 Million | 50.34 Million | 28.69 Million | 21.12 Million | 70.8 Million | 42.9 Million |
| Gross Profit | 17.95 Million | 39.19 Million | 17.78 Million | 21.93 Million | 69.18 Million | 33.05 Million |
| Operating Expenses | 50.19 Million | 128.58 Million | 151.21 Million | 74.56 Million | 120.73 Million | 66.87 Million |
| Selling, General and Administrative Expenses | 12.57 Million | - | 12.57 Million | 12.83 Million | - | 11.74 Million |
| Research and Development Expenses | 15.76 Million | - | 27.93 Million | 61.73 Million | - | 55.13 Million |
| Other Expenses | 21.85 Million | - | 110.7 Million | - | 31.57 Million | - |
| Cost and Expenses | 83.04 Million | 178.92 Million | 179.9 Million | 95.69 Million | 191.54 Million | 109.78 Million |
| Operating Income | -32.23 Million | -89.38 Million | -133.42 Million | -52.63 Million | -51.55 Million | -33.82 Million |
| Interest Expense | - | 11.19 Million | 3.55 Million | 3.81 Million | 16.72 Million | 8.45 Million |
| Income Tax Expense | 663 Thousand | -4.36 Million | 4.68 Million | 317 Thousand | -817 Thousand | -1.06 Million |
| Earnings before Tax | -35.73 Million | -188.52 Million | -136.18 Million | -52.34 Million | -45.97 Million | -18.59 Million |
| Net Income | -32.48 Million | -157.49 Million | -109.53 Million | -47.95 Million | -45.15 Million | -13.67 Million |
| Earnings Per Share Basic | -0.31 | - | -1.13 | -0.50 | - | -0.14 |
| Earnings Per Share Diluted | -0.31 | - | -1.13 | -0.50 | - | -0.14 |
| Weighted Average Shares Outstanding | 105.19 Million | 96.55 Million | 96.58 Million | 96.52 Million | 94.82 Million | 96.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 105.19 Million | 96.55 Million | 96.58 Million | 96.52 Million | 94.82 Million | 96.26 Million |
| Gross Margin | 0.35 | 0.44 | 0.38 | 0.51 | 0.49 | 0.44 |
| EBIT Margin | -0.44 | - | -0.59 | -0.88 | - | -0.24 |
| Profit Margin | -0.64 | -1.76 | -2.36 | -1.11 | -0.32 | -0.18 |
| EBITDA | -22.24 Million | - | -27.38 Million | -37.79 Million | - | -18.59 Million |
| Earnings Before Tax Margin | -0.63 | -1.00 | -2.87 | -1.22 | -0.37 | -0.45 |
0266
AXIL
688128
CNPPF
688565
BORORENEW